CD8+ T-cell lymphoproliferative disorder associated with Epstein-Barr virus in a patient with rheumatoid arthritis during methotrexate therapy

Modern Rheumatology

Volumn 20, Issue 5, 2010, Pages 500-505

  Hatachi, Saori ^a   Kunitomi, Akane ^b   Aozasa, Katsuyuki ^c   Yagita, Masato ^a  

^a Kitano Hospital   (Japan)

^b JAPANESE RED CROSS WAKAYAMA MEDICAL CENTER   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

CD8 T cells; EBV; LPD; MTX; RA

Indexed keywords

ACICLOVIR; C REACTIVE PROTEIN; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CORTICOSTEROID DERIVATIVE; DNA; HEMOGLOBIN; IMMUNOGLOBULIN; INTERLEUKIN 2 RECEPTOR; METHOTREXATE; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; T LYMPHOCYTE RECEPTOR BETA CHAIN; VIRUS DNA;

AGED; ARTICLE; BLOOD CELL COUNT; BLOOD EXAMINATION; BONE MARROW EXAMINATION; BONE MARROW SUPPRESSION; CASE REPORT; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T CELL LYMPHOPROLIFERATIVE DISORDER; CD8+ T LYMPHOCYTE; CEREBROSPINAL FLUID EXAMINATION; CLINICAL ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; CONVULSION; CORTICOSTEROID THERAPY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DNA EXTRACTION; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAPHY; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; ERYTHROCYTE COUNT; FATIGUE; FEMALE; FEVER; FLOW CYTOMETRY; HEPATOSPLENOMEGALY; HOSPITAL ADMISSION; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFECTIOUS MONONUCLEOSIS; LEUKOCYTE COUNT; LOW DRUG DOSE; LYMPH NODE BIOPSY; LYMPHADENOPATHY; LYMPHOCYTE PROLIFERATION; LYMPHOPROLIFERATIVE DISEASE; MENINGOENCEPHALITIS; MONONUCLEAR CELL; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCYTOPENIA; PLEOCYTOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RHEUMATOID ARTHRITIS; SOUTHERN BLOTTING; TONSILLITIS; VIRUS LOAD; VIRUS REACTIVATION;

ACYCLOVIR; AGED; ANTIRHEUMATIC AGENTS; ANTIVIRAL AGENTS; ARTHRITIS, RHEUMATOID; CD8-POSITIVE T-LYMPHOCYTES; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; GENE REARRANGEMENT, BETA-CHAIN T-CELL ANTIGEN RECEPTOR; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOPHENOTYPING; LYMPH NODES; LYMPHOPROLIFERATIVE DISORDERS; MENINGOENCEPHALITIS; METHOTREXATE; METHYLPREDNISOLONE;

EID: 78049328461     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-010-0300-z     Document Type: Article

References (19)

1. E Thomas DH Brewster RJ Black GJ Macfarlane 2000 Risk of malignancy among patients with rheumatic conditions Int J Cancer 88 497 502 1:STN:280: DC%2BD3crgsl2guw%3D%3D 10.1002/1097-0215(20001101)88:3<497::AID-IJC27>3.0. CO;2-J 11054684
2. L Mellemkjaer MS Linet G Gridley M Frisch H Moller JH Olsen 1996 Rheumatoid arthritis and cancer risk Eur J Cancer 32A 1753 1757 1:STN:280:DyaK2s7gsFKntQ%3D%3D 10.1016/0959-8049(96)00210-9 8983286 (Pubitemid 26306889)
3. G Gridley JK McLaughlin A Ekbom L Klareskog HO Adami DG Hacker, et al. 1993 Incidence of cancer among patients with rheumatoid arthritis J Natl Cancer Inst 85 307 311 1:STN:280:DyaK3s7kvVehsQ%3D%3D 10.1093/jnci/85.4.307 8426374
4. Y Hoshida JX Xu S Fujita I Nakamichi J Ikeda Y Tomita, et al. 2007 Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication J Rheumatol 34 322 331 1:CAS:528:DC%2BD2sXjtFCnsbc%3D 17117491
5. Gaulard P, Swerdlow SH, Harris NL, Jaffe ES, Sundstom C. Other iatrogenic immnodeficiency-associated lymphoproliferative disorders. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, editors. WHO classification of tumors of haematopoietic and lymphoid tissues, World Health Organization classification of tumors. IARC Press: Lyon; 2008. p. 350-1.
6. E Salloum DL Cooper G Howe J Lacy G Tallini J Crouch, et al. 1996 Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases J Clin Oncol 14 1943 1949 1:CAS:528:DyaK28XjslOrs7o%3D 8656264
7. X Mariette D Cazals-Hatem J Warszawki F Liote N Balandraud J Sibilia 2002 Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France Blood 99 3909 3915 1:CAS:528:DC%2BD38XktFyrsrg%3D 10.1182/blood.V99.11.3909 12010788 (Pubitemid 35332027)
8. M Kojima H Itoh K Hirabayashi S Igarashi Y Tamaki K Murayama, et al. 2006 Methotrexate-associated lymphoproliferative disorders. A clinicopathological study of 13 Japanese cases Pathol Res Pract 202 679 685 10.1016/j.prp.2006.05. 007 16859835
9. M Kojima H Itoh K Shimizu N Saruki K Murayama K Higuchi, et al. 2006 Malignant lymphoma in patients with systemic rheumatic disease (rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis, and dermatomyositis): a clinicopathologic study of 24 Japanese cases Int J Surg Pathol 14 43 48 1:CAS:528:DC%2BD28XhvFGgs7o%3D 10.1177/106689690601400108 16501834
10. T Miyazaki K Fujimaki Y Shirasugi F Yoshiba M Ohsaka K Miyazaki, et al. 2007 Remission of lymphoma after withdrawal of methotrexate in rheumatoid arthritis: relationship with type of latent Epstein-Barr virus infection Am J Hematol 82 1106 1109 1:CAS:528:DC%2BD2sXhsVyhurjN 10.1002/ajh.21003 17654684 (Pubitemid 350209856)
11. K Hatanaka N Nakamura M Kojima K Ando S Irie M Bunno, et al. 2010 Methotrexate-associated lymphoproliferative disorders mimicking angioimmunoblastic T-cell lymphoma Pathol Res Pract 206 1 9 13 1:CAS:528:DC%2BC3cXjvF2js7o%3D 10.1016/j.prp.2009.03.005 19628340
12. K Dabanaka M Kobayashi T Namikawa R Yoshioka K Okamoto T Okabayashi, et al. 2007 A resected case of splenic T-cell malignant lymphoma (in Japanese) Jpn J Gastroenterol Surg 40 1834 1838
13. D Suzuki J Sawada O Kimoto K Shimoyama N Ogawa 2008 A case of methotrexate-related lymphoproliferative disorder (in Japanese) J Chubu Rheum Assoc 39 120 121
14. Hagino N, Okunishi K, Asada K, Okada Z, Mathumoto T, Shinohara S, et al. A case of immunoblastic T-cell lymphoma during the treatment of RA with methotrexate. J Kanto Rheum Assoc. 2008;41:233-242 (no abstract, in Japanese).
15. CM Weyand JJ Goronzy PJ Kurtin 2006 Lymphoma in rheumatoid arthritis: an immune system set up for failure Arthritis Rheum 54 685 689 1:CAS:528: DC%2BD28XjtV2lsrc%3D 10.1002/art.21674 16508924
16. WH Feng JI Cohen S Fischer L Li M Sneller R Goldbach-Mansky, et al. 2004 Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas J Natl Cancer Inst 96 1691 1702 1:CAS:528:DC%2BD2cXhtVSqsrzP 10.1093/jnci/djh313 15547182 (Pubitemid 39585638)
17. N Balandraud J Roudier C Roudier 2005 What are the links between Epstein-Barr virus, lymphoma, and tumor necrosis factor antagonism in rheumatoid arthritis? Semin Arthritis Rheum 34 5 Suppl1 31 33 1:CAS:528: DC%2BD2MXjtVyrtLc%3D 10.1016/j.semarthrit.2005.01.008 15852253
18. A Komatsuda H Wakui T Nimura K Sawada 2008 Reversible infliximab-related lymphoproliferative disorder associated with Epstein-Barr virus in a patient with rheumatoid arthritis Mod Rheumatol 18 315 318 1:CAS:528: DC%2BD1cXmslyjsLY%3D 10.1007/s10165-008-0053-0 18368468
19. H Fujimoto K Asaoka T Imaizumi M Ayabe H Shoji M Kaji 2003 Epstein-Barr virus infections of the central nervous system Intern Med 42 33 40 10.2169/internalmedicine.42.33 12583615